. VEGF is a multi-tasking cytokine that promotes endothelial survival, migration, proliferation and angiogenesis [8, 9] . We, and others, have shown that VEGF stimulates endothelial proliferation and survival via mitogen-activated protein kinase/extracellular signal-regulated kinase (p42/44-MAPK/ERK1/2) signalling [10] [11] [12] [13] .
Besides survival and proliferation promoting signalling, ERK1/2 pathway also leads to neuronal differentiation of embryonic stem (ES) cell like P19 cells [14] , differentiation and morphogenesis events of gastrulation [15] . Inhibition of MAPK/ERK in ES cells blocked their differentiation into neural or mesodermal cells [16] . [4, [17] [18] [19] [20] [21] [22] [23] .
In addition, MAPK/ERK pathway has been shown to be one of the key signalling pathways in the differentiation of various cell types both in vivo and in vitro, including neuronal cells, ECs, adipocyte and cells of visual cortex
In
the present study, we examined the possibility that VEGF induces the differentiation of mouse MAPCs into ECs via MAPK/ERK1/2 signalling pathway. We show that VEGF induces endothelial differentiation by initiating a sustained activation of MAPK/ERK1/2 in the differentiating mouse MAPCs. Inhibition of ERK1/2 activity prevents endothelial differentiation, suggesting that ERK1/2 signalling pathway plays a key role in the process of mouse MAPC differentiation into EC in vitro.

Materials and methods
Culture of mouse MAPCs
MAPCs were isolated from femurs of 3-to 4-week-old mice using previously established method [6] . The The cultured MAPCs will be tested with karyotyping every two weeks for quality control as previously described [24] . 
Endothelial differentiation from MAPCs
Results
VEGF-induced differentiation of MAPCs to ECs
We 
Phospho-MAPK/ERK1/2 are dynamically activated during the differentiation of MAPCs to ECs
We have shown earlier that eNOS is dynamically expressed during the differentiation of MAPCs to ECs [32] . Fig. 2A) (Fig 4A) . MAPK/ERK phosphorylation remained consistently inhibited up to day 14 in the presence of PD98059 (Fig. 4B) (Fig. 5A) . Furthermore, DiI-Ac-LDL uptake was dramatically reduced in the cells cultured with VEGF in the presence of PD98059 as compared to VEGF alone (Fig. 5B) . [35, 36] Fig. 1 [3, 6, 32] [7] , within 24 hrs of VEGF stimulation. lineages, including ECs. The finding in this study is consistent with previous reports using ES [37, 38] Indeed VEGF is a multi-tasking cytokine which stimulate cell differentiation, survival, proliferation and migration [9] . Many studies show that VEGF is required for the differentiation of stem cells to haematopoietic cells and cardiac myocytes [39] [40] [41] . VEGF (20 ng/ml) [42] . Mouse ES cells and chick embryo require sustained activation of MAPK/ERK1/2 for a specific period for neural specification [43] . (Fig. 3) , but completely inhibited the differentiation of MAPC to EC (Fig. 5) .
Activation of eNOS plays a critical role in VEGF-induced MAPK/ERK phosphorylation in EC [33]. Therefore, we examined if VEGF-induced activation of eNOS in MAPCs also led to the downstream activation of MAPK/ERK signalling. VEGF induced the phosphorylation of MAPK/ERK in a time-dependent manner in the differentiating MAPCs (
Thus, inhibition of MAPK/ERK 1 and 2 phosphorylation by PD98059 results in the inhibition of VEGF-induced differentiation of MAPCs to ECs, both morphologically and functionally.
Nuclear translocation of phospho-MAPK/ERK is required for endothelial differentiation from MAPCs
Phosphorylation of MAPK/ERK1/2 followed by nuclear translocation is required to induce transcriptional changes leading to proliferation, survival and differentiation
. MAPCs incubated with VEGF for 14 days showed the presence of phosphor MAPK/ERK (red) in the nuclei (blue) of MAPCs (Fig. 6B). In the presence of PD98059, however, VEGF-induced MAPK/ERK 1 and 2 phosphorylation as well as nuclear translocation were significantly inhibited on day 14 (Fig. 6C). Thus, VEGF-induced phosphorylation as well as translocation of MAPK/ERK 1 and 2 is required for the differentiation of MAPCs to ECs. In brief, our data show that VEGF stimulates sustained activation and nuclear translocation of MAPK/ERK in the differentiating
MAPCs. This sustained activation and nuclear translocation of MAPK/ERK leads to the differentiation of MAPCs to ECs.
Discussion
Our observations provide a molecular explanation for endothelial specification of progenitor cells. We show for the first time that phosphorylation of MAPK/ERK mediates VEGF-induced differentiation of MAPCs to ECs. Inhibition of MAPK/ERK phosphorylation abolishes the ability of VEGF to induce MAPCs to EC specification. Therefore, MAPK/ERK phosphorylation is critical to the process of endothelial differentiation and development. The ability of VEGF to stimulate EC-specific gene expression and to induce the differentiation of mouse MAPCs to ECs are consistent with earlier observations from our laboratory and others utilizing mouse and human MAPCs
. We show that the time-dependent differentiation of MAPCs into ECs is accompanied by a consistent but slow up-regulation of EC-specific genes up to day 14. In contrast, a sharp decline was observed in the expression of Oct-4, an ES-cell-specific marker that has been found to be highly expressed in MAPCs
It is noticeable that MAPCs lose their identity with down-regulation of Oct-4 expression very early upon stimulation with VEGF that is associated with sustained activation of MAPK/ERK during the course of differentiation into ECs. 'Loss of identity' may be a key step in the commitment of MAPCs to follow different cell
promotes the differentiation of ES cells to cardiac myocytes via MAPK/ERK phosphorylation, and PD98059 inhibits VEGF-induced cardiac myocyte differentiation
Inhibition of MAPK/ERK1/2 stalls the differentiation of ES cells into neural cells even upon FGF5 up-regulation. Pluripotent stem © 2008 The Authors Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 Time course of phospho-MAPK/ERK and MAPK/ERK in undifferentiated and differentiating MAPCs. (A) MAPK/ERK was activated after 15 min. of incubation with VEGF which sustained throughout the observation period of 4 hrs in MAPCs. Control: HUVEC with stimulation by VEGF165 for 10 min. (B) The expression of p42-phospho-MAPK/ERK2 was sustained throughout 14 days in differentiating MAPCs. Membrane was stripped and re-probed with MAPK/ERK that showed the equal loading of the samples. Figures are representative of results obtained from three independent experiments.
Fig. 3 Proliferation assay of MAPCs in the presence
Therefore, inhibition of MAPK/ERK by PD98059 leads to the inhibition of MAPC differentiation to EC and is not due to the inhibition of cell proliferation.
Previous studies have characterized a critical role of Flk1 in the activation of MAPK/ERK pathway in cell proliferation and survival [46, 47] [48] . Also it was found that MAPK/ERK activity is essential for the neuronal differentiation of ES cells [14] . Nerve growth factor-induced neuronal differentiation is exclusively dependent on activation of the MEK/ERK pathway in PC12 cells [19, 20] 
